Skip to main content
. 2019 Sep 26;2019(9):CD013438. doi: 10.1002/14651858.CD013438

Hornamand 2017.

Methods RCT, parallel design
Participants Total number of randomized participants: 105 (number includes participants in an additional group that is not eligible for the review
Inclusion criteria: scheduled for surgery with laryngoscopy
Interventions Labetolol vs normal saline. Study included an additional group (remifentanil), which we will not include in the review
Outcomes Outcomes reported in the abstract: bradycardia; tachycardia; hypotension; hypertension
Notes Awaiting translation from Persian to assess full eligibility; number of participants in each group is not reported. We identified another publication by the same author team (Hornamand 2016) and it is possible that these are associated publications of the same study.